| 摘要 |
Accordingly, the objective of this invention is to establish a means of reducing the probability of viral infection from the AIDS virus at the site of infection outside of the body and prior to AIDS infection. This invention relates to a method that reduces the risk or probability of infection by the AIDS virus (HTLV-III/LAV/ARV) through the use of IPG compounds that provide a safe and efficient source of anions applied in a manner and at a frequency so as to cause a sustained, abnormal concentration of anions in the virally infected tissues in aqueous or lipid phases or both at the time of exposure. |
